Clinical Trial Update: A Study to Evaluate the Pharmacodynamic, Efficacy and Safety of SHR-1703 in Asthma Patients With Eosinophil Phenotype [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pharmacodynamic effects, efficacy and safety of SHR-1703 in asthma patients with eosinophilic phenotype has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• SHR-1703

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Asthma With Eosinophilic Phenotype | Phase 2 | Status: COMPLETED